Fermenta Biotech Ltd

Fermenta Biotech Employee Stock Options

Fermenta Biotech granted 3,95,400 stock options to employees under its 2025 ESOP scheme. The move aims to incentivize personnel while the company seeks direct listing on NSE.

Value

₹3.31 Cr

Execution

3 years

Fermenta Biotech Q4 FY26 Results: Net Profit ₹18.6 Cr, Down 44.1% YoY

Fermenta Biotech Ltd reported revenue from operations of ₹121.6 Cr (-13.0% YoY) and net profit of ₹18.6 Cr (-44.1% YoY) for Q4 FY26.

Key figure

Net profit ₹18.6 Cr · -44.1% YoY

Fermenta Biotech Financial Results

Fermenta Biotech reported audited financial results for FY2026 and recommended a 75% final dividend. The board fixed August 5, 2026, as the record date for payment.

Value

₹0.54 Cr

Fermenta Biotech Board Meeting Date

Fermenta Biotech scheduled a board meeting for May 26, 2026. Directors will consider FY26 audited financial results and a final dividend recommendation.